189 related articles for article (PubMed ID: 25175483)
1. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
[TBL] [Abstract][Full Text] [Related]
2. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
3. Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.
Pfeiffer MJ; Smit FP; Sedelaar JP; Schalken JA
Mol Med; 2011; 17(7-8):657-64. PubMed ID: 21365123
[TBL] [Abstract][Full Text] [Related]
4. Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
Castillo V; Valenzuela R; Huidobro C; Contreras HR; Castellon EA
Int J Oncol; 2014 Sep; 45(3):985-94. PubMed ID: 24990514
[TBL] [Abstract][Full Text] [Related]
5. The role of ATP-binding cassette transporter genes in the progression of prostate cancer.
Karatas OF; Guzel E; Duz MB; Ittmann M; Ozen M
Prostate; 2016 Apr; 76(5):434-44. PubMed ID: 26708806
[TBL] [Abstract][Full Text] [Related]
6. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
9. Stem cell markers in glioma progression and recurrence.
Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
[TBL] [Abstract][Full Text] [Related]
10. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
[TBL] [Abstract][Full Text] [Related]
12. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
13. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
14. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Giercksky KE; Nesland JM; Suo Z
Tumour Biol; 2012 Aug; 33(4):967-78. PubMed ID: 22252524
[TBL] [Abstract][Full Text] [Related]
16. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
17. Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
Hu J; Li J; Yue X; Wang J; Liu J; Sun L; Kong D
Oncotarget; 2017 Apr; 8(17):28463-28470. PubMed ID: 28212529
[TBL] [Abstract][Full Text] [Related]
18. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]